Gilead Sciences Inc (USD)
GILD
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range70.02 | 70.76
52-Wk Range- | -
Last Close70.88
Mkt Cap (m)88,909.99
Dividend yield3.70
ISINUS3755581036
Volume618,351.00
Exchange VenueNAS

Company Profile

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Key Information
Price/Earning-
Price/Book4.90
Price/Sales4.05
P/CF9.97
Rev Growth (3 year avg)-9.60
EPS Growth (3 year avg)-0.25
Operating Margin % 19.10
Net Margin %23.99
Return on Equity24.53
Debt/Equity1.09

Documents

Prospectus
en 18/09/2017
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.gilead.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)24,890.0032,639.0030,390.0026,107.0022,127.0022,449.00
Operating Income (m)15,265.0022,193.0017,633.0014,124.008,200.004,287.00
Net Income (m)12,101.0018,108.0013,501.004,628.005,455.005,386.00
Basic EPS7.9512.3710.083.544.204.24
Avg. Diluted Shares Outstanding (m)1,647.001,521.001,358.001,319.001,308.001,277.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)17,714.0024,763.0020,445.0031,823.0035,836.0030,296.00
Non Current Assets (m)16,950.0027,076.0036,532.0038,460.0027,839.0031,331.00
Total Assets (m)34,664.0051,839.0056,977.0070,283.0063,675.0061,627.00
Current Liabilities (m)5,761.009,891.009,219.0011,635.0010,605.009,759.00
Total Liabilities (m)------
Total Equity (m)15,426.0018,534.0018,887.0020,442.0021,387.0022,525.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)12,818.0020,329.0016,669.0011,898.008,400.009,144.00
Capital Expenditure (m)-557.00-747.00-748.00-590.00-924.00-825.00
Figures are quoted in USD unless stated otherwise
-0.45 (-0.63%)
$
70.43
Last Price